What is the appropriate emergency management for an overdose of lamotrigine (Lamictal) and escitalopram (Lexapro)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Emergency Management of Lamotrigine and Escitalopram Overdose

Immediately hospitalize the patient and provide aggressive supportive care with continuous cardiac monitoring, airway protection, and seizure precautions—there are no specific antidotes for either drug, and lamotrigine can cause life-threatening sodium channel blockade requiring sodium bicarbonate treatment. 1

Immediate Stabilization and Monitoring

Airway and Respiratory Support

  • Establish airway protection early if Glasgow Coma Scale ≤8 or signs of respiratory compromise develop 2
  • Lamotrigine overdose causes CNS depression with decreased level of consciousness and coma in significant ingestions 1
  • Recent data shows 54% of patients with lamotrigine overdoses ≥2g required endotracheal intubation, with higher peak concentrations correlating with need for intubation (p<0.0001) 3

Cardiac Monitoring - Critical Priority

Continuous ECG monitoring is mandatory because:

  • Lamotrigine is a sodium channel blocker that causes QRS prolongation, intraventricular conduction delays, wide complex tachycardia, and cardiovascular collapse 2
  • Escitalopram causes QTc prolongation and tachycardia 4
  • The combination creates dual cardiac risks requiring vigilant monitoring

Seizure Precautions

  • Seizures occur in 20-55% of lamotrigine overdoses 3, 5
  • Administer benzodiazepines (diazepam first-line or midazolam) for seizure treatment 2
  • Children ≤3.5 years are particularly susceptible to seizures at lower doses (≥525mg ingestions) 5

Specific Antidotal and Advanced Therapies

Sodium Bicarbonate for Cardiac Toxicity

It is reasonable to use sodium bicarbonate for life-threatening cardiotoxicity from lamotrigine as a sodium channel blocker 2. Administer if:

  • QRS prolongation develops
  • Wide complex tachycardia occurs
  • Hypotension with conduction delays

Dosing: Hypertonic sodium bicarbonate boluses (1000 mEq/L in adults, 500 mEq/L in children) 2

Important caveat: Sodium bicarbonate yielded no response in 4 of 9 cases with conduction delays in one systematic review 5, but this remains the guideline-recommended intervention.

Intravenous Lipid Emulsion - Rescue Therapy

Consider lipid emulsion for refractory wide complex tachycardia or cardiovascular collapse 2. In one case report, lipid emulsion successfully terminated wide-QRS tachyarrhythmia when sodium bicarbonate failed 6. This is a Class 2b recommendation (may be reasonable) for refractory sodium channel blocker poisoning 2.

Hemodynamic Support

  • 28% of patients with lamotrigine overdose ≥2g required inotropes 3
  • Higher peak lamotrigine concentrations correlate with hypotension requiring inotropic support (p=0.0269) 3
  • Standard vasopressor support per local protocols

Decontamination and Enhanced Elimination

Gastrointestinal Decontamination

  • Activated charcoal if presenting within 1-2 hours of ingestion and airway can be protected 1
  • Emesis may be induced if indicated, with airway protection precautions 1

Extracorporeal Elimination

Consider continuous veno-venous hemodiafiltration (CVVHDF) or hemodialysis for severe, refractory cases 2:

  • Standard hemodialysis removes only ~20% of lamotrigine over 4 hours 1
  • CVVHDF may provide superior continuous drug clearance and level stabilization compared to intermittent hemodialysis 6
  • One case successfully used CVVHDF with adjunctive IV rifampin to accelerate metabolism 6
  • This is a Class 2a recommendation for refractory cardiogenic shock from sodium channel blockers 2

Concentration-Dependent Toxicity Thresholds

Lamotrigine Serum Concentrations

  • Adults: Severe toxicity threshold >25 mg/L, including seizures, cardiac conduction delays, and death 5
  • Children ≤3.5 years: Seizures can occur at concentrations as low as 3.8 mg/L 5
  • Peak concentrations correlate with severe outcomes including seizures (p=0.0002) 3
  • Expect peak levels 4-5 hours post-ingestion 3

Escitalopram Toxicity

  • Generally less toxic than citalopram in overdose 4
  • Median toxic dose ~130mg (vs 310mg for citalopram) 4
  • Seizures rare with escitalopram alone (1/421 cases vs 30/374 with citalopram) 4

Special Considerations for This Combination

Serotonin Toxicity Risk

Monitor closely for serotonin syndrome - 43% of lamotrigine overdose patients developed serotonin toxicity when co-ingesting another serotonergic agent 3:

  • Escitalopram is serotonergic, creating additive risk
  • Severe serotonin toxicity (temperature >38.5°C, rigidity) occurred in 4 patients, requiring muscle paralysis 3
  • Serotonin toxicity was unrelated to lamotrigine concentration but highly associated with co-ingestion of serotonergic agents (67% vs 5%, p<0.0001) 3

Prolonged Elimination

  • Lamotrigine half-life can extend to ~100 hours in overdose due to hepatic metabolic pathway saturation 7
  • Expect prolonged consciousness disturbance beyond typical pharmacokinetics
  • Serial lamotrigine levels help guide duration of monitoring

Disposition and Monitoring Duration

  • All patients require hospitalization 1
  • Frequent vital sign monitoring and close observation 1
  • Continue cardiac monitoring until QRS normalizes and no dysrhythmias for 24 hours
  • Neurological recovery typically occurs by day 6-7 in severe cases 7

Contact Poison Control

Call 1-800-222-1222 (US) for expert toxicology consultation - all poison centers are supported by board-certified toxicologists with specialized training in poisoning resuscitation 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.